TP53 and adenosarcoma: In addition to distinct somatic genetic alterations likely resulting in TERT activation in PTs and adenosarcomas, both tumor types displayed activation of Wnt signaling, as well as enrichment for alterations in p53/pRb/cell cycle‐related pathways (Fig. 5).